50 results on '"Claessen, Bimmer E"'
Search Results
2. Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation
3. Comparison of Age (
4. Outcomes by Gender and Ethnicity After Percutaneous Coronary Intervention
5. Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
6. Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry
7. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention
8. Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry)
9. Meta-Analysis Comparing Complete or Culprit Only Revascularization in Patients With Multivessel Disease Presenting With Cardiogenic Shock
10. A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial
11. Stent Thrombosis: A Clinical Perspective
12. Impact of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump on Prognostically Important Clinical Outcomes in Patients Undergoing High-Risk Percutaneous Coronary Intervention (from the PROTECT II Randomized Trial)
13. In-Stent Restenosis: Is the Future Bioresorbable?
14. Balance of Ischemia and Bleeding in Selecting an Antithrombotic Regimen
15. Vasoactive and Antiarrhythmic Drugs During Percutaneous Coronary Intervention
16. Safety and Efficacy of High- Versus Low-Dose Aspirin After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: The HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
17. Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary Syndromes
18. Predictive Value of Plasma Glucose Level on Admission for Short and Long Term Mortality in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
19. Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents: Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials
20. Impact of In-Hospital Major Bleeding on Late Clinical Outcomes After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
21. Long-Term Impact of Chronic Kidney Disease in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: The HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
22. Long-Term Outcome of Percutaneous Coronary Intervention for Chronic Total Occlusions
23. Impact of Intravascular Ultrasound Imaging on Early and Late Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stents
24. Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction: Analysis From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
25. Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-SWITCH Analysis
26. Impact of Bleeding on Mortality After Percutaneous Coronary Intervention: Results From a Patient-Level Pooled Analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trials
27. Two-Year Safety and Effectiveness of Sirolimus-Eluting Stents (from a Prospective Registry)
28. Impact of Smoking on Outcomes of Patients With ST-Segment Elevation Myocardial Infarction (from the HORIZONS-AMI Trial)
29. Long-Term Clinical Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusions in Patients With Versus Without Diabetes Mellitus
30. Effect of Multivessel Coronary Disease With or Without Concurrent Chronic Total Occlusion on One-Year Mortality in Patients Treated With Primary Percutaneous Coronary Intervention for Cardiogenic Shock
31. Stent Technology Reaches Maturity?
32. FFR in the Setting of ACS: Can We Do Better?
33. 600.09 In-Hospital Outcomes of Patients with Bicuspid Aortic Valve Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Analysis
34. Go With the Flow When Instantaneous Wave-Free Ratio-Fractional Flow Reserve Discordance Occurs: Indeed, Beware When Relying on Fractional Flow Reserve Alone
35. Paravalvular Leak: An Interesting Interplay of Acquired vWF-Disease and Late Bleeding After TAVR
36. Revascularization Strategies in Cardiogenic Shock Patients With MVD: For Now, Keep it Simple
37. MKL1 C–184>T AND CYP3A5 A–6986>G POLYMORPHISMS ARE ASSOCIATED WITH CONTRAST INDUCED ACUTE KIDNEY INJURY AFTER PCI
38. Reply
39. PROCEDURAL AND LONG-TERM CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION OF CHRONIC TOTAL OCCLUSIONS IN WOMEN: A REPORT FROM THE MULTINATIONAL CTO REGISTRY
40. RELATIONSHIP BETWEEN BIOMARKERS AND SUBSEQUENT CLINICAL AND ANGIOGRAPHIC RESTENOSIS AFTER PACLITAXEL-ELUTING STENTS FOR TREATMENT OF STEMI: A HORIZONS-AMI SUBSTUDY
41. DISCHARGE MEDICATION USE IN PATIENTS WHO EXPERIENCE BLEEDING COMPLICATIONS AFTER PRIMARY PCI: ANALYSIS FROM HORIZONS-AMI
42. RELATIONSHIP BETWEEN BIOMARKERS AND SUBSEQUENT ADVERSE ISCHEMIC AND BLEEDING EVENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY
43. TWO-YEAR OUTCOMES WITH EVEROLIMUS-ELUTING STENTS VS. PACLITAXEL-ELUTING STENTS ACCORDING TO LESION LENGTH AND VESSEL DIAMETER: POOLED ANALYSIS FROM THE SPIRIT II, III, IV AND COMPARE RANDOMIZED TRIALS
44. LONG-TERM CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC TOTAL OCCLUSIONS IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS: FIVE-YEAR OUTCOMES FROM A 1,791 PATIENT MULTI-NATIONAL REGISTRY
45. IMPACT OF MULTIVESSEL DISEASE WITH AND WITHOUT A CONCURRENT CHRONIC TOTAL OCCLUSION ON SHORT AND LONG-TERM MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH AND WITHOUT CARDIOGENIC SHOCK
46. CLINICAL UTILITY OF BIOMARKERS TO PREDICT STENT THROMBOSIS AFTER STEMI TREATED WITH DES: A HORIZONS-AMI SUBSTUDY WITH 3-YEAR FOLLOW-UP
47. RELATIONSHIP BETWEEN BIOMARKERS AND SUBSEQUENT MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY
48. COMPARISON OF LONG TERM CLINICAL PROGNOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO THE PRESENCE OF IN-HOSPITAL MAJOR BLEEDING EVENTS: 3 YEAR FOLLOW-UP RESULT OF HORIZONS-AMI
49. IMPACT OF CHRONIC KIDNEY DISEASE ON LONG-TERM OUTCOMES IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION AND ALTERNATIVE ANTITHROMBOTIC TREATMENT STRATEGIES: A HORIZONS-AMI SUBSTUDY
50. Thrombus Aspiration in Primary Percutaneous Coronary Intervention: How to Manage Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.